News

Eppendorf Award 2021: Call for Entries

09/01/2020

The Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, is granted annually to an early career scientist in Europe for...

Randall Platt: Hijacking the CRISPR System to Create ‘Living Diagnostics’

08/27/2020

Nature Podcast with Randall Platt, Eppendorf Award Winner 2020

BioNews No. 53. Just Keep Moving: Move It®!

07/01/2020

Move It® is a new generation of multi-channel pipettes with adjustable tip spacing.

New epServices Tile in the Eppendorf App

06/15/2020

Your instruments deserve the best service and maintenance for a long life. That’s why we offer you epServices to calibrate your pipettes, check security of your centrifuges, or verify the temperatures of your PCR cycler. Of course there are many more services for all products available.

Eppendorf Planet of Knowledge – A new Dimension

06/11/2020 - 06/11/2021

We are pleased to introduce you to the Eppendorf Planet of knowledge, a new virtual platform, where One-Day-Events will be held on specific themes, topics and product launches.

Eppendorf AG: Supervisory Board appoints new Chief Financial Officer

06/02/2020

> Axel Jaeger becomes new Chief Financial Officer of Eppendorf AG

Eppendorf significantly expands capacities for the production of consumables

05/15/2020

> Construction of two additional production halls at the Oldenburg site

> Strong capacity expansion by 30 percent from 2021

Free Webinar on Improving qPCR Reliability with Smart Plastics

05/13/2020

This Eppendorf webinar together with Michael Pfaffl, one of the qPCR pioneers, will show you how to improve qPCR reliability and reproducibility using smart plastics.

Free Webinar on Nucleic Acid Purification

04/21/2020

Nucleic Acid Purification – Understanding the details, tackle the routines!

Eppendorf AG posts a strong fiscal year 2019

04/20/2020

> Revenue rises to €803.9 million (prior year: €729.2 million)

> At 10.2%, revenue growth exceeds industry average

> Operating profit reaches €144.2 million with an EBIT margin of 17.9%

> All sales regions and product groups are developing positively

> R&D investments increase by 11.2% to €50.3 million